155 related articles for article (PubMed ID: 17060982)
1. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.
Knight V; Koshkina NV; Golunski E; Roberts LE; Gilbert BE
Trans Am Clin Climatol Assoc; 2004; 115():395-404; discussion 404. PubMed ID: 17060982
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.
Koshkina NV; Golunski E; Roberts LE; Gilbert BE; Knight V
J Aerosol Med; 2004; 17(1):7-14. PubMed ID: 15120008
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.
Koshkina NV; Waldrep JC; Roberts LE; Golunski E; Melton S; Knight V
Clin Cancer Res; 2001 Oct; 7(10):3258-62. PubMed ID: 11595722
[TBL] [Abstract][Full Text] [Related]
4. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
[TBL] [Abstract][Full Text] [Related]
6. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391
[TBL] [Abstract][Full Text] [Related]
7. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
[TBL] [Abstract][Full Text] [Related]
8. Prevention of local tumor growth with paclitaxel-loaded microspheres.
Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
10. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP).
Shin HJ; Kim YS; Kwak YS; Song YB; Kim YS; Park JD
Planta Med; 2004 Nov; 70(11):1033-8. PubMed ID: 15549658
[TBL] [Abstract][Full Text] [Related]
12. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
[TBL] [Abstract][Full Text] [Related]
13. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
[TBL] [Abstract][Full Text] [Related]
15. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
Hershey AE; Kurzman ID; Forrest LJ; Bohling CA; Stonerook M; Placke ME; Imondi AR; Vail DM
Clin Cancer Res; 1999 Sep; 5(9):2653-9. PubMed ID: 10499645
[TBL] [Abstract][Full Text] [Related]
16. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells.
Lövey J; Fazekas K; Ladányi A; Németh G; Tímár J
Strahlenther Onkol; 2003 Dec; 179(12):812-8. PubMed ID: 14652669
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
18. Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors.
Ho EA; Soo PL; Allen C; Piquette-Miller M
J Control Release; 2007 Jan; 117(1):20-7. PubMed ID: 17113177
[TBL] [Abstract][Full Text] [Related]
19. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel.
Negishi T; Koizumi F; Uchino H; Kuroda J; Kawaguchi T; Naito S; Matsumura Y
Br J Cancer; 2006 Sep; 95(5):601-6. PubMed ID: 16909136
[TBL] [Abstract][Full Text] [Related]
20. Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect.
Koudelka S; Turánek-Knötigová P; Masek J; Korvasová Z; Skrabalová M; Plocková J; Bartheldyová E; Turánek J
J Pharm Sci; 2010 May; 99(5):2309-19. PubMed ID: 19904827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
